Trial suggests that perindopril reduces major cardiovascular events among people with stable coronary artery disease: Abstracted from: The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362(9386): 782–8

• Book ID: 116415642
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 131 KB
• Volume: 8
• Category: Article
• ISSN: 1361-2611
• DOI: 10.1016/j.ebcm.2003.12.023